Osman R. Minkara is the founder and managing principal of CIG Corp., a wealth management and advisory services firm in metro Detroit. Since its inception in 1997, Mr. Minkara has developed the firm into a substantial niche provider in wealth management and business advisory services for individuals and institutions throughout the United States. Under his leadership, the company has developed an extensive suite of traditional and alternative wealth management services, with a focus on health care. CIG has a world-renowned medical advisory board and a large majority of clients in the health care field. Mr. Minkara serves on multiple boards, including Oakland County (Michigan) Economic Roundtable, Wayne University Executive Board and GenerationOne. Mr. Minkara has a bachelor of science degree in finance and is magna cum laude from Wayne State University. He participated in the Advanced Management Programme at Oxford University and holds a joint Executive MBA from New York University, London School of Economics and HEC in Paris. He has earned multiple honors in recent years, including designation as the 2010 FIVE STAR Wealth Manager, a distinction given to fewer than seven percent of the wealth managers in the Detroit area. Other awards include Wayne State University Emerging Corporate Leader and Crain’s Detroit Business 40 under 40 (top 40 executives in Michigan under 40 years of age). In addition, he has been interviewed on financial matters by multiple media outlets, including CBS and ABC.
Mr. Wolf is focused on creating, financing, nurturing, and growing new ventures based on breakthrough research and technology. Prior to founding GenerationOne, Mr. Wolf founded and was the Managing Partner of Seed-One Ventures, a firm focused on identifying and acquiring cutting-edge ideas and technologies and the systematic formation and management of early-stage, high-growth companies based on these breakthroughs. Jeff founded and served as Chairman/CEO of several medical technology companies including TyRx Pharma, a company focused on the development of bio-compatible polymers; EluSys Therapeutics, a company focused on the development of a novel technology to remove blood-borne pathogens; Avigen, a San Francisco-based gene therapy company; and Sensatex, a Maryland company focused on the development of novel medical diagnostic systems.
Mr. Wolf received an MBA from Stanford Business School, a J.D. from New York University School of Law and a B.A. with Honors in Economics from the University of Chicago.
Mr. Meadow is the Faculty Director of Global Initiatives and since 2000 has held the position of Clinical Professor of Entrepreneurship at the University of Chicago Booth School of Business. Scott Meadow has over 25 years experience as a general partner with four venture capital and private equity firms including William Blair Venture Partners, The Frontenac Company, The Sprout Group and most recently with the Edgewater Funds, where he remains a Senior Advisor. Over the course of his career, Scott has approved hundreds of equity financings, been active in fund-raising and has personally led, originated or created more than sixty investments including two dozen healthcare services companies. Mr. Meadow has been recognized four times by Venture One as one of the outstanding healthcare investors in the industry. He was designated by Business Week’s “Guide to the Best Business Schools” as one of the outstanding entrepreneurial professors in the country. Professor Meadow has taught 5000 students at Chicago Booth, in Entrepreneurial Finance and Private Equity, Commercializing Innovation (which he created) and the New Venture Challenge.
Professor Meadow earned his A.B. Magna Cum Laude from Harvard College and his M.B.A. from Harvard Business School.